Dermatomyositis associated with omalizumab therapy for severe asthma: a case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1710-1492
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dermatomyositis associated with omalizumab therapy for severe asthma: a case report ; volume:15 ; number:1 ; day:17 ; month:1 ; year:2019 ; pages:1-5 ; date:12.2019
Allergy, asthma and clinical immunology ; 15, Heft 1 (17.1.2019), 1-5, 12.2019
- Creator
-
Jeimy, Samira
Basharat, Pari
Lovegrove, Fiona
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13223-019-0319-4
- URN
-
urn:nbn:de:101:1-2019021822403094702732
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jeimy, Samira
- Basharat, Pari
- Lovegrove, Fiona
- SpringerLink (Online service)
Other Objects (12)
Severe asthma and the omalizumab option
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
Tailored therapy for severe asthma
Biological therapy for severe asthma
Omalizumab Transitions in Severe Asthma: Factors Influencing Switching Decisions and Timing for Optimal Response
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
Severe asthma and the omalizumab option
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
Tailored therapy for severe asthma
Biological therapy for severe asthma
Omalizumab Transitions in Severe Asthma: Factors Influencing Switching Decisions and Timing for Optimal Response
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
Severe asthma and the omalizumab option
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
Follicular T Helper and Breg Cell Balance in Severe Allergic Asthma Before and After Omalizumab Therapy
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
Tailored therapy for severe asthma
Biological therapy for severe asthma
Omalizumab Transitions in Severe Asthma: Factors Influencing Switching Decisions and Timing for Optimal Response